Chemical Synthesis

General
All commercially available reagents were used without further purification. Aldehyde 1 was prepared as previously described. 1 All N-glycans were provided by Glytech, Inc. Azidefunctionalized N-glycans a-f were prepared according to the previously reported procedure. 2 Ultrapure water from Merck Milli-Q Advantage® was used for all synthetic experiments described in this paper. Reverse phase HPLC analysis/purification was performed on a Shimadzu Prominence® system equipped with a Nacalai tesque column (5C18-AR-300, 4.6 x 250 mm). Two solvent systems, namely, A: H 2 O containing 0.1% TFA and B: MeCN containing 0.1% TFA, were applied. High-resolution mass spectra (HRMS) were obtained on a Bruker micrOTOF-QIII spectrometer® by electron spray ionization (ESI-TOF-MS). Mass spectra of the glycan-conjugated albumins were obtained on a Bruker autoflex spectrometer® by matrix assisted laser desorption ionization (MALDI-TOF MS), using 2,5-dihydroxybenzoic acid as a matrix.
Preparation of glycoalbumins
Preparation of α(2,6)-disialoglycan-modifying probe 1a (prepared as the stock solution to be used below for homogeneous and heterogeneous glycoalbumin synthesis)
To a solution of α(2,6)-disialoglycan a (1.2 mg, 0.50 µmol) in DMSO (139 µL) was added 10 mM solution of aldehyde 1 in MeCN (45 µL, 0.45 µmol) under nitrogen atmosphere.
The resulting mixture was heated to 70 °C and monitored by HPLC (gradient: from 10% B/90% A to 100% B over 30 min. While the aldehyde 1 was detected at 27.5 min, the clicked product 1a was observed at 17.7 and 17.9 min (regioisomers at triazole ring)). After the consumption of the starting aldehyde 1, the mixture was cooled down to RT to give 3.8 mM stock solution of 1a, which was analyzed by ESI After the disappearance of the starting aldehyde 1, the mixture was cooled down to RT, and diluted with DMSO (44 µL) and water (88 µL). Subsequently, FL750-HSA stock solution prepared above (88 µL, 5.0 nmol) was added and the resulting solution was incubated overnight at 37 °C. The mixture was centrifuged through Amicon 10K® at 15,000 rpm for 10 min, and further washed with water three times to filter off any small molecules. The insoluble byproducts were further removed by filtering with Durapore rpm for 10 min, and further washed with water three times to filter off any small molecules.
The insoluble byproducts were further removed by filtering with Durapore PVDF 0.45 µm® and diluted with water to give 100 µL solution of hybrid-type glycoalbumin 2f. MALDI-TOF-MS (positive mode) detected the molecular weight of 2f at 94.0 kDa, which contains average number, 9.9 molecules of glycan f per albumin.
MALDI-TOF-MS of 2f
[M] + To a diluted solution of the sialylated intermediate (44 µL, 1.0 nmol) obtained above was added 2.0 µL stock solution of asialoglycan-modifying probe 1c as prepared previously (7.5 nmol, 7.5 eq) and the mixture was incubated at 37 °C overnight. The resulting solution was diluted with water and centrifuged through Amicon 10K® at 15,000 rpm for 10 min, and further washed with water three times to filter off any small molecules.
The insoluble byproducts were removed by filtering with Durapore PVDF 0.45 µm® and diluted with water to give 50 mM solution of heterogeneous glycoalbumin 2g. MALDI-TOF-MS (positive mode) detected the molecular weight of 2g at 103.9 kDa, which therefore contained 2.6 molecules of glycan c per albumin (total number of glycans introduced to albumin was 10.9).
MALDI-TOF-MS of 2g
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Preparation of heterogeneous glycoalbumin 2j with asialo-and α(2,6)-disialoglycans 
